Thalidomide April 12, 2017 Thalidomide Trade Name Thalomid Orphan Indication Myelodysplastic syndrome USA Market Approval USA USA Designation Date 2004-09-27 00:00:00 Sponsor Celgene Corporation;86 Morris Avenue;Summit, New Jersey, 07901
